The anti-IgE autoantibodies are biomarkers of early omalizumab response
in patients with chronic spontaneous urticaria
- Yusuke Niwa,
- Koremasa Hayama,
- Shota Toyoshima,
- Keisuke Shimizu,
- Maho Tagui,
- Mana Ito,
- Tomomi Sasaki-Sakamoto,
- Tadashi Terui,
- Hideki Fujita,
- Yoshimichi Okayama
Yusuke Niwa
Nihon Daigaku Igakubu Daigakuin Igaku Kenkyuka Gekakei
Author ProfileKoremasa Hayama
Nihon Daigaku Igakubu Daigakuin Igaku Kenkyuka Gekakei
Author ProfileKeisuke Shimizu
Nihon Daigaku Igakubu Daigakuin Igaku Kenkyuka Gekakei
Author ProfileMaho Tagui
Nihon Daigaku Igakubu Daigakuin Igaku Kenkyuka Gekakei
Author ProfileMana Ito
Nihon Daigaku Igakubu Daigakuin Igaku Kenkyuka Gekakei
Author ProfileTomomi Sasaki-Sakamoto
Nihon Daigaku Igakubu Daigakuin Igaku Kenkyuka Naikakei
Author ProfileTadashi Terui
Nihon Daigaku Igakubu Daigakuin Igaku Kenkyuka Gekakei
Author ProfileHideki Fujita
Nihon Daigaku Igakubu Daigakuin Igaku Kenkyuka Gekakei
Author ProfileSubmission Checks Completed
Assigned to Editor
Reviewer(s) Assigned
26 Jun 2024Review(s) Completed, Editorial Evaluation Pending
30 Jun 2024Reviewer(s) Assigned
15 Jul 2024Editorial Decision: Revise Minor
01 Nov 20241st Revision Received
07 Nov 2024Submission Checks Completed
07 Nov 2024Assigned to Editor
07 Nov 2024Review(s) Completed, Editorial Evaluation Pending
07 Nov 2024Reviewer(s) Assigned
14 Nov 2024Editorial Decision: Accept